
A TEESSIDE man has become the first NHS patient in the country to be given a new immunotherapy drug for the treatment of lung cancer. Ken Hall,

Sylvia Lewis, 78, was able to start taking a new drug called Osimertinib in June – four months before it was approved for general NHS use When

A lung cancer patient given just months to live is taking part in a pioneering clinical trial on Teesside. Just weeks after being diagnosed Kathleen Gilligan has